Time-zero renal biopsy in living kidney transplantation: A valuable opportunity to correlate predonation clinical data with histological abnormalities

Transplantation

Volumn 86, Issue 12, 2008, Pages 1684-1688

  Mancilla, Eduardo ^a   Avila Casado, Carmen ^a   Uribe Uribe, Norma ^b   Morales Buenrostro, Luis E ^b   Rodríguez, Francisco ^a   Vilatoba, Mario ^b   Gabilondo, Bernardo ^b   Aburto, Salvador ^a   Rodríguez, Roxana M ^b   Magaña, Salvador ^a   Magaña, Fernando ^a   Alberú, Josefina ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Donor biopsy; Living kidney donor; Renal allograft biopsy; Time zero biopsy

Indexed keywords

CREATININE;

ADULT; ARTICLE; ATROPHY; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; BIOPSY; BLOOD PRESSURE; CONGENITAL MALFORMATION; GLOMERULUS; HOSPITAL ADMISSION; KIDNEY; KIDNEY CIRCULATION; KIDNEY DISEASE; PATHOLOGY; PATIENT SELECTION; PHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME;

BIOPSY; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; PATIENT SELECTION; PROTEINURIA; RENAL CIRCULATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WAITING LISTS;

EID: 58849150846     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181906150     Document Type: Article

References (35)

1. http://www.cenatra.gob.mx/cnt/Grafica-totphp?s-organo=Riñon. Accessed July 22, 2008.
2. Terasaki PI, Cecka JM, Gjertson DW, et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
3. Cecka JM. The UNOS Scientific Renal Transplant Registry. Clin Transpl 1999: 1.
4. Gossmann J, Wilhelm A, Kachel HG, et al. Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. Am J Transplant 2005; 5: 2417.
5. Guidi E, Cozzi M, Milani S, et al. Nephrectomy modifies renal angiotensin II effects in kidney donors. Am J Hypertens 2008; 21: 592.
6. Fehrman-Ekholm I, Dunér F, Brink B, et al. No evidence of accelerated loss of kidney function in living kidney donors: Results from a cross-sectional follow-up. Transplantation 2001; 72: 444.
7. Najarian JS, Chavers BM, McHugh LE, et al. 20 years or more of follow-up of living kidney donors. Lancet 1992; 340: 807.
8. Ramcharan T, Matas AJ. Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant 2002; 2: 959.
9. Isoniemi H. Living kidney donation; a surgeon's opinion. Nephrol Dial Transplant 1997; 12: 1828.
10. Delmonico F; Council of the Transplantation Society. A report of the Amsterdam forum on the care of the live kidney donor: Data and medical guidelines. Transplantation 2005; 79(6 suppl): s53.
11. Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 2001; 1(suppl2):3.
12. Pham PC, Wilkinson AH, Pham PT. Evaluation of the potential living kidney donor. Am J Kidney Dis 2007; 50: 1043.
13. Davis CL. Evaluation of the living kidney donor: Current perspectives. Am J Kidney Dis 2004; 43: 508.
14. Andreoni KA, Wilson K, Nickeleit V. Findings from baseline renal biopsies in live and deceased donor renal transplantation. Am J Transplant 2005; 5(suppl): s325 [abstract#661].
15. Rea DJ, Heimbach JK, Grande JP, et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006; 70: 1636.
16. Stegall MD, Ramos EJ, Lager D, et al. Ruling out occult renal disease in living kidney donors: Evidence from time zero biopsies. Transplantation 2006; (suppl): s788 [abstract# 2181].
17. Narins SC, Dube GK, Cohen DJ, et al. Are normal kidneys normal? Unsuspected renal histopathology among living kidney donors despite comprehensive pre-operative evaluation. Am J Transplant 2007; 7(suppl): s170 [abstract# 91].
18. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
19. Bajwa M,Cho YW, Pham PT, etal. Donor biopsy and kidney transplant outcomes: An analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 2007; 84: 1399.
20. HowieAJ, FerreiraMA,Lipkin GW,etal. Measurementof chronic damage in the donor kidney and graft survival. Transplantation 2004; 77: 1058.
21. Kayler LK, Mohanka R, Morgan C, et al. Correlation of histologic findings on pre-implant biopsy with kidney graft survival. Am J Transplant 2008; 8(suppl): s218 [abstract# 149].
22. Ghazanfar A, McWilliam L, Tavakoli A. Can day zero cadaver donor renal allograft biopsy predict the long term outcomeofrecipient's renal functions? Am J Transplant 2008; 8(suppl): s367 [abstract# 703].
23. Issa N, Meyer KH, Arrigain S, et al. Evaluation of creatinine-based estimates of glomerular filtration rate in a large cohort of living kidney donors. Transplantation 2008; 86: 223.
24. Lowery K, Morrissey P, Gautam A, et al. Living kidney donor age and kidney biopsy findings do not predict donor renal function outcomes. Am J Transplant 2007; 7(suppl): s560 [abstract# 1610].
25. Woestenburg A, Sennesael J, Bosmans JL, et al. Vasculopathy in the kidney allograft at time of transplantation: Impact on later function of the graft. Transplantation 2008; 85(7 suppl): S10.
26. Escofet X, Osman H, Griffiths DF, et al. The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantation. Transplantation 2003; 75: 344.
27. Gracida C, Espinoza R, Cedillo U, et al. Kidney transplantation with living donors: Nine years of follow-up of 628 living donors. Transplant Proc 2003; 35: 946.
28. Gai M, Giunti S, Lanfranco G, et al. Potential risks of living kidney donation - A review. Nephrol Dial Transplant 2007; 22: 3122.
29. Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801.
30. Ellison MD, McBride MA, Taranto SE, et al. Living kidney donors in need of kidney transplants: A report from the organ procurement and transplantation network. Transplantation 2002; 74: 1349.
31. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México, Instituto Nacional de Salud Pública 2006.
32. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
33. Fehrman-Ekholm I, Nordén G, Lennerling A, et al. Living kidney donors developing end-stage renal disease. Transplant Proc 2006; 38: 2642.
34. Rosenblatt GS, Nakamura N, Barry JM. End-stage renal disease after kidney donation: A single-center experience. Transplant Proc 2008; 40: 1315.
35. Davis CL. Variable evaluation and selection criteria for living kidney donors: Have we gotten the message yet? Am J Transplant 2007;7:2219.